Skip to main content

Hooker Furnishings Reports Profitability Despite Challenging Market Conditions

MARTINSVILLE, Va., June 11, 2026 (GLOBE NEWSWIRE) — Hooker Furnishings Corporation (NASDAQ-GS: HOFT) (“Hooker” or the “Company”), a global leader in home furnishings, today reported its operating results for its fiscal 2027 first quarter ended May 3, 2026. Key Results for the Fiscal 2027 First Quarter:The Company generated operating income of $1.6 million in the first quarter of fiscal 2027, compared to an operating loss of $498,000 in the prior-year period, a $2.1 million improvement. Consolidated net sales decreased $1.7 million, or 2.4%, but consolidated gross profit increased $2.7 million, and gross margin improved 440 basis points. Hooker Branded drove profitability improvement, with gross profit increasing $2.9 million, and gross margin improving 960 basis points, contributing $1.2 million of operating income despite a...

Continue reading

Regulatory release no. 6 – 2026: New long-term share-based incentive programme

New long-term share-based incentive programme With reference to the offering circular (the “Offering Circular”) published by InstallatørGruppen A/S (“InstallatørGruppen” or the “Company”, and together with its consolidated subsidiaries, the “Group”) as described in company announcement 1-2026 dated 3 June 2026, the Board of Directors of InstallatørGruppen has today implemented a new long-term incentive programme (the “LTIP”). The LTIP is designed and structured around the concept of retaining members of the Executive Management and other eligible employees while also creating an incentive for a positive share price development for the benefit of the Company’s shareholders. The LTIP grants comprise stock options which entitle the participant, subject to vesting occurring, to be allocated a number of shares in the Company, equivalent...

Continue reading

Erik Thedéen: The banks should regularly test their operational capacity to borrow from the Riksbank

Banks and other monetary policy counterparties need to ensure that they have the operational capacity and readiness to borrow money from the Riksbank, emphasised Governor Erik Thedéen when he took part in a panel discussion at the Stockholm International Banking Crisis Management Conference.  “The Riksbank’s monetary policy counterparties shall regard the Riksbank’s lending facilities and market operations as a natural part of their daily liquidity management. To ensure that banks can borrow from the Riksbank quickly and efficiently when needed, we are considering introducing mandatory test transactions, but as a first step, our counterparties are now recommended to voluntarily test their operational capacity by borrowing from the Riksbank.” The banks can test their operational capacity by borrowing any amount from the Riksbank’s lending...

Continue reading

MAY VOLUMES: MIXED GROWTH ACROSS ROUTE NETWORK

INVESTOR NEWS no. 18 – 11 June 2026 Ferry – freight: In May 2026, total volumes of 3.6m lane metres were 1.8% below 2025 and down 1.7% adjusted for route changes. North Sea volumes were above 2025 following higher volumes on most routes. Mediterranean volumes were overall below 2025, partly due to a higher number of Turkish public holidays in May 2026 compared to 2025. Volume growth on the Egypt and Tunisia routes continued. Channel volumes were below 2025 driven by lower volumes on the Dover Strait. Baltic Sea volumes were well above 2025 and Strait of Gibraltar volumes were also above 2025. For the last twelve months, the total transported freight lane metres increased 0.3% to 41.8m from 41.7m in 2025-24 and decreased 1.5% adjusted for route changes. Ferry – passenger: In May 2026, the number of passengers adjusted for...

Continue reading

Oculis to Present Privosegtor at Upcoming Clinical Trials at the Summit 2026

ZUG, Switzerland, June 11, 2026 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in neuro-ophthalmology and ophthalmology, today announced an upcoming presentation at Clinical Trials at the Summit 2026, taking place on June 12-13, 2026, in Las Vegas, Nevada. Oculis is a proud sponsor of Clinical Trials at the Summit 2026, which brings together experts from around the world to discuss ongoing clinical trials and the latest data, all with the goal of achieving advances in vitreoretinal care. Details of Oculis’ presentation are as follows: Clinical Trials at the Summit 2026:Privosegtor in Optic Neuritis: From Discovery to PIONEER Registrational TrialsPresenter: Riad Sherif, M.D.,...

Continue reading

MAY VOLUMES: MIXED GROWTH ACROSS ROUTE NETWORK

INVESTOR NEWS no. 18 – 11 June 2026 Ferry – freight: In May 2026, total volumes of 3.6m lane metres were 1.8% below 2025 and down 1.7% adjusted for route changes. North Sea volumes were above 2025 following higher volumes on most routes. Mediterranean volumes were overall below 2025, partly due to a higher number of Turkish public holidays in May 2026 compared to 2025. Volume growth on the Egypt and Tunisia routes continued. Channel volumes were below 2025 driven by lower volumes on the Dover Strait. Baltic Sea volumes were well above 2025 and Strait of Gibraltar volumes were also above 2025. For the last twelve months, the total transported freight lane metres increased 0.3% to 41.8m from 41.7m in 2025-24 and decreased 1.5% adjusted for route changes. Ferry – passenger: In May 2026, the number of passengers adjusted for...

Continue reading

Oculis to Present Privosegtor at Upcoming Clinical Trials at the Summit 2026

ZUG, Switzerland, June 11, 2026 – Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in neuro-ophthalmology and ophthalmology, today announced an upcoming presentation at Clinical Trials at the Summit 2026, taking place on June 12-13, 2026, in Las Vegas, Nevada. Oculis is a proud sponsor of Clinical Trials at the Summit 2026, which brings together experts from around the world to discuss ongoing clinical trials and the latest data, all with the goal of achieving advances in vitreoretinal care. Details of Oculis’ presentation are as follows: Clinical Trials at the Summit 2026:Privosegtor in Optic Neuritis: From Discovery to PIONEER Registrational TrialsPresenter: Riad Sherif, M.D., Chief Executive OfficerDate/Time:...

Continue reading

Share Buyback Transaction Details June 4 – June 10, 2026

PRESS RELEASE                                         Share Buyback Transaction Details June 4 – June 10, 2026 Alphen aan den Rijn – June 11, 2026 – Wolters Kluwer (Euronext: WKL), a global leader in professional information solutions, software and services, today reports that it has repurchased 61,431 of its own ordinary shares in the period from June 4, 2026, up to and including June 10, 2026, for €3.9 million and at an average share price of €63.23. These repurchases are part of the share buyback program announced on February 25, 2026, under which we intend to repurchase shares for up to €500 million during 2026. The cumulative amounts repurchased in the year to date under this program are as follows: Share Buyback 2026Period Cumulative shares repurchased in period Total consideration(€ million) Average share price(€)2026...

Continue reading

Invitation to conference call with web presentation of SkiStar AB’s Interim Report for the third quarter 2025/26

SkiStar AB will publish the Interim Report for the period 1 September 2025 – 31 May 2026 on Thursday 18 June 2026 at 07.00 a.m. CEST. In connection with the report SkiStar will organize a conference call with web presentation. CEO Stefan Sjöstrand and CFO Sara J Uggelberg will present and comment on the report. After the presentation there will be time for questions, both by phone and by chat in the web presentation. The presentation will be held in English. Time for conference call and web presentation Thursday 18 June 2026 at 10.00 a.m. CEST.Web cast: https://edge.media-server.com/mmc/p/or5am947 Web cast & participation at conference call to ask questions:https://register-conf.media-server.com/register/BIf3806da592dc4db68526b12b5a71feb1 For registration and dial-in details, please follow the link above. Please make sure you are...

Continue reading

Crédit Agricole Financement de l’Habitat SFH : EARLY REPURCHASE OF ISIN FR001400JM17

Montrouge, June 11, 2026 Crédit Agricole Financement de l’Habitat SFH ANNOUNCES EARLY REPURCHASE OF EUR 3,250,000,000 “obligations de financement de l’habitat” Fixed Rate Notes issued on July 28, 2023 and due December 15, 2026 (ISIN: FR001400JM17)* Crédit Agricole Financement de l’Habitat SFH (the “Issuer”) announces today the early repurchase (the « Repurchase ») with effect on June 16, 2026 (the « Repurchase Date ») of all of its outstanding EUR 3,250,000,000 “obligations de financement de l’habitat” Fixed Rate Notes issued on July 28, 2023 and due December 15, 2026 (ISIN: FR001400JM17) (the « Notes ») pursuant to the Terms and Conditions of the Notes (the “Terms and Conditions”) included in the prospectus dated July 20, 2023, which was granted the visa n°23-326 by the Autorité des marchés financiers on July...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.